Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.

by Laurie Adami

The U.S. Preventive Services Task Force lowers its recommended age to begin colorectal cancer screening to 45, and a major multiple myeloma study begins in Iceland.

by Bradley Jones

Testing for hereditary mutations is increasingly recommended for people with cancer, but recommendations do not always translate into access to testing and appropriate counseling.

by Kate Yandell

At a patient advocate event, researchers discussed how to extend the benefits of immunotherapy to more people.

by Kevin McLaughlin

Testing children with cancer for hereditary mutations could impact their treatment and provide information relevant to other family members.

by Marcus A. Banks

Researchers are investigating who is at greatest risk for radiation-induced cancers.

by Kate Yandell

For people with melanoma who receive immune checkpoint inhibitors after surgery, side effects can remain even after treatment has been completed. These chronic side effects are most often mild.

by Anna Goshua

Anti-racism activist and historian Ibram X. Kendi opens up about his stage IV colon cancer treatment, and the FDA approves an immunotherapy drug for endometrial cancer

by Marci A. Landsmann

Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.

by Marci A. Landsmann

The immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors.

by Kate Yandell